Cargando…
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors
Background: Patients with schizophrenia (SZ) are generally overweight or obese and have several metabolic disorders. Additionally, such patients have a lower life expectancy and the main cause of their increased mortality is cardiovascular disease (CVD). The objective of this study was to determine...
Autores principales: | Zortea, Karine, Franco, Viviane C., Francesconi, Lenise P., Cereser, Keila M. M., Lobato, Maria Inês R., Belmonte-de-Abreu, Paulo S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772037/ https://www.ncbi.nlm.nih.gov/pubmed/26840331 http://dx.doi.org/10.3390/nu8020073 |
Ejemplares similares
-
Physical Functional Capacity and C-Reactive Protein in Schizophrenia
por: Szortyka, Michele Fonseca Vieira, et al.
Publicado: (2016) -
Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial
por: Zortea, Karine, et al.
Publicado: (2016) -
Aerobic and Postural Strength Exercise Benefits in People with Schizophrenia
por: Szortyka, Michele Fonseca, et al.
Publicado: (2023) -
A controlled open clinical trial of the positive effect of a physical intervention on quality of life in schizophrenia
por: Cristiano, Viviane Batista, et al.
Publicado: (2023) -
Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs
por: Szortyka, Michele Fonseca, et al.
Publicado: (2021)